Search Results - "Hirji, Alim"

Refine Results
  1. 1

    Clinical transplantation using negative pressure ventilation ex situ lung perfusion with extended criteria donor lungs by Buchko, Max T., Boroumand, Nasim, Cheng, Jeffrey C., Hirji, Alim, Halloran, Kieran, Freed, Darren H., Nagendran, Jayan

    Published in Nature communications (13-11-2020)
    “…Lung transplantation remains the best treatment option for end-stage lung disease; however, is limited by a shortage of donor grafts. Ex situ lung perfusion,…”
    Get full text
    Journal Article
  2. 2

    Relative Lung Perfusion on Ventilation–Perfusion Scans After Double Lung Transplant by Li, David J., Abele, Jonathan, Sunner, Parveen, Varughese, Rhea A., Hirji, Alim S., Weinkauf, Justin G., Nagendran, Jayan, Weatherald, Jason C., Lien, Dale C., Halloran, Kieran M.

    Published in Transplantation (01-10-2023)
    “…Pulmonary blood flow can be assessed on ventilation-perfusion (VQ) scan with relative lung perfusion, with a 55% to 45% (or 10%) right-to-left differential…”
    Get full text
    Journal Article
  3. 3

    Disease recurrence after lung transplantation for idiopathic pulmonary hemosiderosis by Ross, Bryan, Halloran, Kieran, Adam, Benjamin, Laing, Bryce, Hirji, Alim

    Published in Respiratory medicine case reports (01-01-2020)
    “…Idiopathic pulmonary hemosiderosis is characterized by the triad of hemoptysis, iron deficiency anemia and pulmonary infiltrates. Though idiopathic pulmonary…”
    Get full text
    Journal Article
  4. 4

    Multi-dimensional scores to predict mortality in patients with idiopathic pulmonary fibrosis undergoing lung transplantation assessment by Fisher, Jolene H., MD, Al-Hejaili, Faris, MD, Kandel, Sonja, MD, Hirji, Alim, MD, Shapera, Shane, MD, Mura, Marco, MD, PhD

    Published in Respiratory medicine (01-04-2017)
    “…Abstract Background The heterogeneous progression of idiopathic pulmonary fibrosis (IPF) makes prognostication difficult and contributes to high mortality on…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Tuberculosis in HIV-infected persons in British Columbia during the HAART era by Cheng, Matthew P., Hirji, Alim, Roth, David Z., Cook, Victoria J., Lima, Viviane D., Montaner, Julio S., Johnston, James C.

    Published in Canadian journal of public health (01-07-2014)
    “…OBJECTIVE:Prior to the introduction of highly active antiretroviral therapy (HAART), active tuberculosis (TB) was a major contributor to HIV-related morbidity…”
    Get full text
    Journal Article
  7. 7

    Outcome of Fetuses and Infants With Double Inlet Single Left Ventricle by Tham, Edythe B.C., MBBS, Wald, Rachel, MD, McElhinney, Doff B., MD, Hirji, Alim, MD, Goff, Donna, MD, Del Nido, Pedro J., MD, Hornberger, Lisa K., MD, Nield, Lynne E., MD, Tworetzky, Wayne, MD

    Published in The American journal of cardiology (01-06-2008)
    “…Double-inlet left ventricle (DILV) includes a diverse range of anatomic variables that affect the surgical strategy. The aim of this study was to determine the…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Lung Transplantation from Hepatitis C Viremic Donors to Uninfected Recipients by Abdelbasit, Ahmed, Hirji, Alim, Halloran, Kieran, Weinkauf, Justin, Kapasi, Ali, Lien, Dale, Nagendran, Jayan, Doucette, Karen

    “…Lung recipients receive higher-intensity immunosuppression than renal recipients, and can rarely be initiated on oral therapy immediately after transplant…”
    Get full text
    Journal Article
  11. 11

    Chest X-ray Sizing for Lung Transplants Reflects Pulmonary Diagnosis and Body Composition and Is Associated With Primary Graft Dysfunction Risk by Li, David, Weinkauf, Justin, Hirji, Alim, Nagendran, Jayan, Kapasi, Ali, Lien, Dale, Halloran, Kieran

    Published in Transplantation (01-02-2021)
    “…BACKGROUND:Donor-recipient oversizing based on predicted total lung capacity (pTLC) is associated with a reduced risk of primary graft dysfunction (PGD)…”
    Get full text
    Journal Article
  12. 12

    Baseline lung allograft dysfunction in primary graft dysfunction survivors after lung transplantation by Li, David, Weinkauf, Justin, Kapasi, Ali, Hirji, Alim, Varughese, Rhea, Lien, Dale, Nagendran, Jayan, Halloran, Kieran

    Published in Respiratory medicine (01-11-2021)
    “…Primary graft dysfunction (PGD) after lung transplantation has previously been associated with increased risk of death and chronic lung allograft dysfunction…”
    Get full text
    Journal Article
  13. 13

    Pretransplant Opioid Use and Survival After Lung Transplantation by Vahidy, Sana, Li, David, Hirji, Alim, Kapasi, Ali, Weinkauf, Justin, Laing, Bryce, Lien, Dale, Halloran, Kieran

    Published in Transplantation (01-08-2020)
    “…PURPOSE:The impact of opioid use in lung transplant candidates on posttransplant outcomes is unknown. Studies on opioid therapy in kidney and liver transplant…”
    Get full text
    Journal Article
  14. 14

    Baseline lung allograft dysfunction is associated with impaired survival after double-lung transplantation by Liu, Jonathan, Jackson, Kathy, Weinkauf, Justin, Kapasi, Ali, Hirji, Alim, Meyer, Steve, Mullen, John, Nagendran, Jayan, Lien, Dale, Halloran, Kieran

    “…The prognostic value of defining normal vs abnormal baseline post-transplant lung function (or baseline lung allograft dysfunction [BLAD]) has not been studied…”
    Get full text
    Journal Article
  15. 15

    Successful Long-Term Outcome After Transplantation of Lungs Affected by Smoke Inhalation Injury by Moolji, Jalal, Gill, Ishrat, Varughese, Rhea, Adam, Benjamin, Halloran, Kieran, Weinkauf, Justin, Lien, Dale, Mullen, John, Hirji, Alim

    Published in The Annals of thoracic surgery (01-07-2022)
    “…We report a case of a 43-year-old woman who underwent double lung transplantation from a donor with severe airway burns following a house fire. The recipient’s…”
    Get full text
    Journal Article
  16. 16

    Pre-transplant malignancy is associated with increased risk of de novo malignancy post-lung transplantation by Sekowski, Viktor, Jackson, Kathy, Halloran, Kieran, Varughese, Rhea, Nagendran, Jayan, Weinkauf, Justin, Lien, Dale, Hirji, Alim

    Published in Respiratory medicine (01-06-2022)
    “…At least 20% of lung transplant recipients will be diagnosed with a malignancy within 5 years of transplant. Transplant candidates with a history of…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Safety of Crossing Donor-specific Antibodies in Lung Transplantation by Wang, Melissa, Campbell, Patricia, Lien, Dale C., Varughese, Rhea, Weinkauf, Justin, Nagendran, Jayan, Hirji, Alim, Li, David, Halloran, Kieran

    Published in Transplantation (01-05-2023)
    “…Donor-specific antibodies (DSAs) have been associated with antibody-mediated rejection, chronic lung allograft dysfunction (CLAD), and increased mortality in…”
    Get full text
    Journal Article
  20. 20

    Coronary Artery Disease and Coronary Artery Bypass Grafting at the Time of Lung Transplantation Do Not Impact Overall Survival by Halloran, Kieran, Hirji, Alim, Li, David, Jackson, Kathy, Kapasi, Ali, Meyer, Steve, Mullen, John, Lien, Dale, Weinkauf, Justin

    Published in Transplantation (01-10-2019)
    “…BACKGROUND.Coronary artery disease (CAD) is common in lung transplant candidates and may require revascularization before or at the time of their transplant…”
    Get full text
    Journal Article